Antimicrobial Agents Practice Questions

Q: All of the following are risk factors for renal toxicity caused by aminoglycosides EXCEPT:

Simultaneous use of penicillin. ***Simultaneous use of penicillin*** - Penicillins are **not considered a major risk factor** for aminoglycoside nephrotoxicity. - While aminoglycosides and penicillins can be inactivated when mixed **in vitro** (in IV solutions), this does not translate to a protective effect against renal toxicity **in vivo**. - The major nephrotoxic drug combinations with aminoglycosides include **vancomycin, amphotericin B, cyclosporine, NSAIDs, and loop diuretics** - not penicillins. *Hypokalemia* - **Electrolyte imbalances**, such as hypokalemia, can worsen renal function and increase the susceptibility of the kidneys to damage from nephrotoxic drugs like aminoglycosides. - **Volume depletion** and electrolyte disturbances are common comorbidities that exacerbate aminoglycoside-induced acute kidney injury. *Aminoglycoside administration in recent past* - Prior exposure to aminoglycosides, especially within a short period, can lead to **cumulative toxicity** due to incomplete renal recovery from previous dosing. - The kidneys require time to regenerate epithelial cells damaged by aminoglycosides, and repeated exposure increases the risk of **irreversible damage**. *Elderly patient* - **Age** is a significant risk factor because elderly patients often have **decreased renal blood flow** and a reduced number of functional nephrons. - The **glomerular filtration rate (GFR)** naturally declines with age, making the kidneys more vulnerable to drug-induced injury.

Q: What is the treatment of choice for Campylobacter infections?

Erythromycin. Erythromycin - **Erythromycin**, a macrolide antibiotic, is the **correct answer among the given options** for *Campylobacter* infections. - It works by inhibiting bacterial protein synthesis at the 50S ribosomal subunit, effectively reducing the duration and severity of symptoms in acute gastroenteritis. - **Modern practice note:** While azithromycin (another macrolide) has largely replaced erythromycin as the **preferred first-line agent** due to better tolerability, once-daily dosing, and fewer GI side effects, erythromycin remains effective and is the best choice listed here [1]. - Macrolides are particularly indicated in severe cases with high fever, bloody diarrhea, or in immunocompromised patients. *Tetracycline* - While tetracyclines have broad-spectrum activity, they are **not first-line treatment** for *Campylobacter* due to increasing resistance rates globally [2]. - Resistance mechanisms include efflux pumps and ribosomal protection proteins. - May still have some role in regions with documented susceptibility, but macrolides are preferred. *Ampicillin* - **Ampicillin** and other beta-lactam antibiotics are **ineffective** against *Campylobacter* species. - *Campylobacter* possesses intrinsic resistance to beta-lactams through beta-lactamase production and altered penicillin-binding proteins. - Cell wall synthesis inhibitors are therefore not useful for this infection. *Ciprofloxacin* - **Ciprofloxacin** and other fluoroquinolones were previously common first-line agents but are **no longer recommended** due to widespread resistance. - Resistance rates exceed 50-90% in many countries, particularly linked to fluoroquinolone use in poultry farming. - Should only be used if susceptibility testing confirms sensitivity, which is rarely practical in acute gastroenteritis.

Q: Drug of choice for rheumatic fever prophylaxis in a penicillin-allergic patient is?

Erythromycin. ***Erythromycin*** - **Erythromycin** is the **recommended alternative** for **rheumatic fever prophylaxis** in patients with **penicillin allergy** according to **American Heart Association (AHA) guidelines**. - Typical regimen: **Erythromycin estolate 250 mg BID** or **erythromycin ethylsuccinate 400 mg BID**. - Effective against **Streptococcus pyogenes** (Group A Streptococcus), the causative organism of acute rheumatic fever. - While macrolide resistance exists in some regions, erythromycin remains the **guideline-recommended choice** when penicillin cannot be used. *Clindamycin* - **Clindamycin** is **not recommended** by major guidelines (AHA, WHO) for routine rheumatic fever prophylaxis. - Lacks adequate evidence and official guideline support for this specific indication. - May be considered in specific cases but is not the standard alternative. *Vancomycin* - **Vancomycin** is reserved for **multidrug-resistant infections** such as **MRSA**. - Not indicated for rheumatic fever prophylaxis due to high cost, need for IV administration, and potential for resistance development. - Reserved for life-threatening infections where other options have failed. *Gentamycin* - **Gentamycin** is an **aminoglycoside** used primarily for **severe gram-negative infections**. - Lacks adequate activity against **Streptococcus pyogenes**. - Not appropriate for rheumatic fever prophylaxis.

Q: All of the following bind to the 50S ribosomal unit except:

Tetracycline. ***Tetracycline*** - **Tetracyclines** bind to the **30S ribosomal subunit**, specifically inhibiting protein synthesis by blocking the binding of aminoacyl-tRNA to the A-site. - This mechanism is distinct from the other listed antibiotics which target the 50S subunit. *Macrolide* - **Macrolide antibiotics** bind to the **50S ribosomal subunit** to inhibit bacterial protein synthesis by blocking translocation and peptidyl transferase activity. - This binding prevents the ribosome from moving along the mRNA, effectively halting protein elongation. *Lincosamide* - **Lincosamides**, such as clindamycin, also bind to the **50S ribosomal subunit** at a site overlapping with macrolides and chloramphenicol. - They inhibit protein synthesis by hindering peptidyl transferase and stalling chain elongation. *Chloramphenicol* - **Chloramphenicol** binds to the **50S ribosomal subunit** and inhibits protein synthesis by blocking the peptidyl transferase activity. - This prevents the formation of peptide bonds between amino acids, thereby stopping protein chain elongation.

Question 1

All of the following are risk factors for renal toxicity caused by aminoglycosides EXCEPT:

Accepted Answer

Simultaneous use of penicillin

Answer

Hypokalemia

Answer

Aminoglycoside administration in recent past

Answer

Elderly patient

Question 2

What is the treatment of choice for Campylobacter infections?

Accepted Answer

Erythromycin

Answer

Tetracycline

Answer

Ampicillin

Answer

Ciprofloxacin

Question 3

Drug of choice for rheumatic fever prophylaxis in a penicillin-allergic patient is?

Accepted Answer

Erythromycin

Answer

Vancomycin

Answer

Gentamycin

Answer

Clindamycin

Question 4

All of the following bind to the 50S ribosomal unit except:

Accepted Answer

Tetracycline

Answer

Macrolide

Answer

Lincosamide

Answer

Chloramphenicol

Question 5

Which specific beta-lactamase inhibitor is commonly used to enhance the efficacy of beta-lactam antibiotics in the treatment of bacterial endocarditis?

Accepted Answer

Tazobactam

Answer

Clavulanic acid

Answer

Sulbactam

Answer

Avibactam

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?